The Significant Role of a Functional Polymorphism in the NF-κB1 Gene in Breast Cancer: Evidence from an Iranian Cohort

References

• Siegel RL , MillerKD. Cancer statistics. CA Cancer J. Clin.70(1), 7–30 (2020).
   PubMed Web of Science ®Google Scholar
• Khorshid Shamshiri A , AfzaljavanF, AlidoustMet al. ESR1 gene variants, haplotypes and diplotypes may influence the risk of breast cancer and mammographic density. Mol. Biol. Rep.47(11), 8367–8375 (2020).
   PubMed Web of Science ®Google Scholar
• DeSantis CE , MaJ, GaudetMMet al. Breast cancer statistics, 2019. CA Cancer J. Clin.69(6), 438–451 (2019).
   PubMed Web of Science ®Google Scholar
• Afzaljavan F , MoezziA, VahedniaEet al. Predictive and prognostic value of LSP1 rs3817198 in sporadic breast cancer in northeastern population of Iran. Exp. Mol. Pathol.116, 104514 (2020).
   PubMed Web of Science ®Google Scholar
• Foulkes WD . Inherited susceptibility to common cancers. N. Engl. J. Med.359(20), 2143–2153 (2008).
   PubMed Web of Science ®Google Scholar
• Tajbakhsh A , AfzaljavanF, RivandiMet al. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population. Mol. Biol. Rep.46(1), 805–811 (2019).
   PubMed Web of Science ®Google Scholar
• Beinke S , LeySC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J.382(Pt 2), 393–409 (2004).
   PubMedGoogle Scholar
• Sun XF . NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol. Histopathol.22(12), 1387–1398 (2008).
   Web of Science ®Google Scholar
• Chen F , CastranovaV, ShiX, DemersL. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem.45(1), 7–17 (1999).
   PubMed Web of Science ®Google Scholar
• Heron E , DeloukasP, van LoonAP. The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction. Genomics30(3), 493–505 (1995).
   PubMed Web of Science ®Google Scholar
• Bianco B , LernerTG, TrevisanCM, CavalcantiV, ChristofoliniDM, BarbosaCP. The nuclear factor-kB functional promoter polymorphism is associated with endometriosis and infertility. Hum. Immunol.73(11), 1190–1193 (2012).
   PubMed Web of Science ®Google Scholar
• Tew GW , LorimerEL, BergTJ, ZhiH, LiR, WilliamsCL. SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma. J. Biol. Chem.283(2), 963–976 (2008).
   PubMed Web of Science ®Google Scholar
• Weichert W , BoehmM, GekelerVet al. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br. J. Cancer97(4), 523–530 (2007).
   PubMed Web of Science ®Google Scholar
• Scartozzi M , BearziI, PierantoniCet al. Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab–irinotecan therapy. J. Clin. Oncol.25(25), 3930–3935 (2007).
   PubMed Web of Science ®Google Scholar
• Karban AS , OkazakiT, PanhuysenCIet al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet.13(1), 35–45 (2004).
   PubMed Web of Science ®Google Scholar
• Lewander A , ButchiAK, GaoJet al. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand. J. Gastroenterol.42(11), 1332–1338 (2007).
   PubMed Web of Science ®Google Scholar
• Sima X , XuJ, LiJ, YouC. Association between NFKB1-94 insertion/deletion ATTG polymorphism and risk of intracranial aneurysm. Genet. Test. Mol. Biomarkers17(8), 620–624 (2013).
   PubMed Web of Science ®Google Scholar
• Hegazy DM , O’ReillyDA, YangBM, HodgkinsonAD, MillwardBA, DemaineAG. NFκB polymorphisms and susceptibility to type 1 diabetes. Genes Immun.2(6), 304–308 (2001).
   PubMed Web of Science ®Google Scholar
• Pordel S , NematiK, KarimiMH, DoroudchiM. NF-κB1 Rs28362491 mutant allele frequencies along the silk road and beyond. Iran. J. Public Health47, 397–406 (2018).
   PubMed Web of Science ®Google Scholar
• Cheng CW , SuJL, LinCWet al. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS ONE8(2), e56130–e56130 (2013).
   PubMed Web of Science ®Google Scholar
• Lin SC , LiuCJ, YehWI, LuiMT, ChangKW, ChangCS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett.243(1), 47–54 (2006).
   PubMed Web of Science ®Google Scholar
• Riemann K , BeckerL, StruweHet al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet. Genomics16(11), 783–788 (2006).
   PubMed Web of Science ®Google Scholar
• Eskandari-Nasab E , HashemiM, EbrahimiM, AmininiaS. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC. Cancer Epidemiol. Biomark. Prev.16(1), 109–115 (2016).
   Google Scholar
• Mehrjoo Z , FattahiZ, BeheshtianMet al. Distinct genetic variation and heterogeneity of the Iranian population. PLoS Genet.15(9), e1008385 (2019).
   PubMed Web of Science ®Google Scholar
• Tajbakhsh A , FazeliM, RezaeeMet al. Prevalence of CCR5delta32 in northeastern Iran. BMC Med. Genet.20(1), 184 (2019).
   PubMed Web of Science ®Google Scholar
• Derenko M , MalyarchukB, BahmanimehrAet al. Complete mitochondrial DNA diversity in Iranians. PLoS ONE8(11), e80673 (2013).
   PubMed Web of Science ®Google Scholar
• Amirshahi P , SunderlandE, FarhudDD, TavakoliSH, DaneshmandP, PapihaSS. Population genetics of the peoples of Iran I. genetic polymorphisms of blood groups, serum proteins and red cell enzymes. Int. J. Anthropol.7(3), 1–10 (1992).
   Google Scholar
• Vajpeyi R . WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs. J. Clin. Pathol.58(6), 671–672 (2005).
   PubMedGoogle Scholar
• Andersen V , ChristensenJ, OvervadK, TjønnelandA, VogelU. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer10, 484 (2010).
   PubMed Web of Science ®Google Scholar
• Zhanga P , WeiaQ, LiXet al. A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet. Cytogenet.191(2), 73–77 (2009).
   PubMedGoogle Scholar
• Lo SS , ChenJH, WuCW, LuiWY. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery145(3), 280–285 (2009).
   PubMed Web of Science ®Google Scholar
• Demoulin S , HerfsM, DelvenneP, HubertP. Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms. J. Leukoc. Biol.93(3), 343–352 (2013).
   PubMed Web of Science ®Google Scholar
• Huo ZH , ZhongHJ, ZhuYS, XingB, TangH. Roles of functional NFKB1 and beta-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility. Genet Mol. Res.12(3), 3435–3443 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou B , QieM, WangYet al. Relationship between NFKB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann. Oncol.21(3), 506–511 (2010).
   PubMed Web of Science ®Google Scholar
• Chang ET , BirmannBM, KasperzykJLet al. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev.18(3), 976–986 (2009).
   PubMed Web of Science ®Google Scholar
• Zou YF , YuanFL, FengXLet al. Association between NFKB1-94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest.29(1), 78–85 (2011).
   PubMed Web of Science ®Google Scholar
• Ling J , KumarR. Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy. Cancer Lett.322, 119–126 (2012).
   PubMed Web of Science ®Google Scholar
• Ghosh S , KarinM. Missing pieces in the NF-Kappa B puzzle. Cell109(Suppl.), S81–S96 (2002).
   PubMed Web of Science ®Google Scholar
• Barkett M , GilmoreTD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene18(49), 6910–6924 (1999).
   PubMed Web of Science ®Google Scholar
• Nelson DE , IhekwabaAE, ElliottMet al. Oscillations in NF-kappa B signaling control the dynamics of gene expression. Science306(5696), 704–708 (2004).
   PubMed Web of Science ®Google Scholar
• Kurt RA , UrbaWJ, SmithJW, SchoofDD, PeripheralT. Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules. Int. J. Cancer78(1), 16–20 (1998).
   PubMed Web of Science ®Google Scholar
• Song S , ChenD, LuJet al. NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS ONE6(6), e21726 (2011).
   PubMed Web of Science ®Google Scholar